Why the study?
Hypoglycemia increases sudden death risk in diabetes mellitus, but the molecular mechanisms by which it aggravates diabetic cardiomyopathy progression remain to be elucidated.
Does hypoglycemia challenge exacerbate cardiac dysfunction and aberrant electrophysiology in diabetic cardiomyopathy models?
Population
Streptozotocin-induced DCM mice, neonatal mouse ventricular myocytes, and cardiomyocytes from patients with DM
Comparison
Hypoglycemia challenge and mtCx43 overexpression vs controls
Design
Preclinical animal and cellular mechanistic study
Authors
Loading...
Should not yet change practice; leaves open mitochondrial connexin 43 as a therapeutic target in hypoglycemia-aggravated DCM.
Does hypoglycemia challenge exacerbate cardiac dysfunction and aberrant electrophysiology in diabetic cardiomyopathy models?
Hypoglycemia exacerbates diabetic cardiomyopathy by promoting mitochondrial accumulation of Connexin 43, identifying mtCx43 as a potential therapeutic target to prevent hypoglycemia-induced cardiac dysfunction.
Wei et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: